Can Low-Dose Avandia for Diabetes Avoid Lethal Side Effects?

Amid calls to pull the controversial diabetes drug Avandia from the market, new research suggests that a low dose of this GlaxoSmithKline drug may help prevent diabetes without undue risk. Though the study, published Wednesday in the Lancet, showed few adverse side effects for a low-dose treatment, diabetes experts say Avandia has a history of potentially lethal side effects, and that further testing and use of this dangerous drug is questionable. "This is a desperate attempt to salvage a...Full Story
Commenting on this article is closed.